×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AVR – anteris technologies global corp. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AVR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/26
02:01 pm
avr
Anteris Technologies Global (NASDAQ:AVR) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Anteris Technologies Global (NASDAQ:AVR) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/17
06:00 am
avr
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
Medium
Report
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
11/12
05:52 pm
avr
Anteris Announces Results for the Third Quarter of 2025
Medium
Report
Anteris Announces Results for the Third Quarter of 2025
11/3
07:00 am
avr
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
Medium
Report
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
10/30
12:25 pm
avr
Anteris Technologies Global (NASDAQ:AVR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Anteris Technologies Global (NASDAQ:AVR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
10/28
06:08 pm
avr
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
Low
Report
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
10/27
05:43 pm
avr
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
Medium
Report
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
10/27
08:43 am
avr
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
Medium
Report
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/4
06:04 am
avr
Form 8-K Anteris Technologies For: Dec 03
Low
Report
Form 8-K Anteris Technologies For: Dec 03
12/1
04:43 pm
avr
Form 8-K Anteris Technologies For: Nov 26
Medium
Report
Form 8-K Anteris Technologies For: Nov 26
11/17
06:11 am
avr
Form 8-K Anteris Technologies For: Nov 17
High
Report
Form 8-K Anteris Technologies For: Nov 17
11/14
04:45 pm
avr
Form SCHEDULE 13G Anteris Technologies Filed by: Nantahala Capital Management, LLC
Medium
Report
Form SCHEDULE 13G Anteris Technologies Filed by: Nantahala Capital Management, LLC
11/13
06:00 am
avr
Form 8-K Anteris Technologies For: Nov 12
Medium
Report
Form 8-K Anteris Technologies For: Nov 12
11/12
06:15 pm
avr
Form SCHEDULE 13G/A Anteris Technologies Filed by: L1 Capital Pty Ltd
Medium
Report
Form SCHEDULE 13G/A Anteris Technologies Filed by: L1 Capital Pty Ltd
11/12
04:08 pm
avr
Form 10-Q Anteris Technologies For: Sep 30
Medium
Report
Form 10-Q Anteris Technologies For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: